Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences -February 09, 2024 at 08:32 am EST

Fort Lee, NJ, Feb. 09, 2024 -- Nuvectis Pharma, Inc. , a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious...

Related Keywords

Christopherm Calabrese ,Ron Bentsur ,Nasdaq ,Healthcare Life Sciences Conference ,Nuvectis Pharma Inc ,Drug Administration ,Company Contact ,Fort Lee ,Chief Executive Officer ,Annual Healthcare Life Sciences Conference ,Cancer Oncology Conference ,Nuvectis Pharma ,Fast Track Designation ,Orphan Drug Designation ,Markets ,